Analysts' Actions: Alibaba, Oracle, Sprouts, Texas Capital, More

NEW YORK (TheStreet) -- RATINGS CHANGES

Alibaba (BABA) was initiated with a buy rating at Cantor Fitzgerald. Twelve-month price target is $90. Company has an unfair competitive advantage with outsized growth and margin profiles, Cantor said.

Bio-Rad Laboratories (BIO) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: BIO Ratings Report.

Read More: Warren Buffett's Top 10 Dividend Stocks

Oracle (ORCL) was downgraded at Deutsche Bank to hold from buy. Twelve-month price target is $42. Database license sales are slowing down, Deutsche Bank said.

Koss (KOSS) was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: KOSS Ratings Report.

Sprouts (SFM) was initiated with an overweight rating at Barclays. Twelve-month price target is $37. Company can average 33% earnings growth over the next five years, Barclays said.

Texas Capital (TCBI) was upgraded at Wunderlich to buy from hold. Twelve-month price target is $75. Company is the most sensitive to higher interest rates, Wunderlich said.

VF (VFC) was upgraded at Keybanc to buy. Twelve-month price target is $80. Estimates were also increased, as the company will likely improve brands and could make acquisitions, Keybanc said.

Read More: Investors, Make No Mistake -- Larry Ellison Still Runs Oracle

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

If you liked this article you might like

IPOs That Should Be on Your Radar

Wall Street Deflates in Pullback After Fed Excitement, No Records for Dow

Markets Recede From All-Time Highs on Tech Selloff

Tech Sector Sits at Bottom of Wall Street as Apple Continues Its Slide